SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001640334-23-002286
Filing Date
2023-12-08
Accepted
2023-12-08 16:31:06
Documents
3

Document Format Files

Seq Description Document Type Size
1 FORM 424B3 lxrp_424b3.htm 424B3 98650
2 lxrp_s1img1.jpg GRAPHIC 14676
3 lxrp_s1img2.jpg GRAPHIC 14676
  Complete submission text file 0001640334-23-002286.txt   140446
Mailing Address 100 - 740 MCCURDY ROAD KELOWNA A1 V1X 2P7
Business Address 100 - 740 MCCURDY ROAD KELOWNA A1 V1X 2P7 250-765-6424
Lexaria Bioscience Corp. (Filer) CIK: 0001348362 (see all company filings)

IRS No.: 202000871 | State of Incorp.: NV | Fiscal Year End: 0831
Type: 424B3 | Act: 33 | File No.: 333-275810 | Film No.: 231475845
SIC: 2834 Pharmaceutical Preparations